drugset / Trial / NCT00798083

Neuropathic Pain Caused by Radiation Therapy

NCT00798083

Phase 3 Completed 22 enrolled British Columbia Cancer Agency
NaSingle-groupOpen-labelTreatment

Summary

To investigate if topical amitriptyline 2%, ketamine 1%, and lidocaine 5% in pluronic lecitine organogel (AKL in PLO gel) can improve management of neuropathic pain from radiation skin reactions adjunctively or better than standard treatment.

Timeline

Start
2008-04
Primary completion
2009-07
Completion
2009-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Amitriptyline Small molecule 2 % Topical
Subject Ketamine Small molecule 1 % Topical
Subject Lidocaine Other / unclassified 5 % Topical